Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Implantable Materials for Drug Delivery in Tissue Regeneration"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 20 April 2023 | Viewed by 10261
Special Issue Editors
Interests: drug delivery; pharmaceutical technology; biomedical engineering; artificial intelligence
Interests: drug delivery; regenerative medicine; biomaterials; biomedical engineering; pharmaceutical technology
Special Issue Information
The incorporation of new technologies into the field of regenerative medicine over the past few decades has led to the production of new biomaterials tailor-made to fulfill the patient’s needs. Ideally, these biomaterials must be completely degradable under the physiological conditions leading to the repair of the damaged tissue, maintaining the desired structure. The integration of therapeutic molecules into biomaterials can provide extra value to implantable systems. The use of biomaterials loaded with drugs—either for the transfer of drugs in situ or for the promotion of a specific cellular microenvironment—has been suggested as an interesting strategy to treat different pathologies, avoid surgical complications derived from the implantation of materials, and/or promote the regeneration of tissues.
Traditionally, bone has been the most commonly targeted tissue for the development of biomaterials loaded with drugs. However, today, these systems are designed for other applications, such as skin, cartilage, and cardiovascular tissue, among others. The development of these delivery systems and the optimization of existing ones require experience in the fields of both biomaterial engineering and pharmaceutical technology.
This Special Issue aims to identify the current progress in the design, development, and evaluation of implantable materials for drug delivery in tissue regeneration.
Prof. Dr. Mariana Landin
Dr. Patricia Diaz-Rodriguez
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- local drug delivery
- drug-loaded biomaterials
- implantable systems
- tissue regeneration
- biomimetic biomaterials
- drug release profile
- in vitro testing
- preclinical studies